Newsroom

Sorted by: Latest

-

Herbalife Plans to Refinance Senior Secured Debt

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced plans to refinance its senior secured debt. The Company is targeting $1.55 billion of secured financing, which is expected to include a $425 million revolving credit facility, a $125 million Term Loan A, a $500 million Term Loan B and $500 million of other secured debt. The refinancing is also expected to extend the maturity profile of the senior secured debt....
-

FHLBank Chicago and Spring Bank Award Grants to Strengthen Affordable Housing Talent Pipeline in Milwaukee and Increase Housing Supply

MILWAUKEE--(BUSINESS WIRE)--The Federal Home Loan Bank of Chicago, in partnership with member Spring Bank, Brookfield, Wis., last week presented two Community First® Developer Program (Developer Program) awards to Milwaukee-based developers AK Development and Milwaukee Development Corporation. The awards support paid internships and fellowships that build hands-on experience for emerging professionals advancing affordable housing across Wisconsin. Since launching the Developer Program in 2022,...
-

Picsart Launches Aura - Delivering Social Content and Short-Form Videos in Minutes

MIAMI--(BUSINESS WIRE)--Picsart, a leading photo and video editing platform, launches a new AI collaborator, Aura....
-

Pelage Pharmaceuticals Appoints New Board Member and Expands Executive Leadership Team

LOS ANGELES--(BUSINESS WIRE)--Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced the appointment of Maykin Ho, Ph.D., to its board of directors, and the promotions of Nathan Wheeler to Chief Operating Officer and Lisa Sherman to Vice President, Head of Clinical Operations. “We are pleased to welcome Maykin to Pelage’s board as an independent director and to announce key leadership promotions within our organization,” said Daniel Gil, Ph.D., Chi...
-

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the Company will participate in the TD Cowen 46th Annual Health Care Conference and Leerink Partners Global Healthcare Conference in Boston and Miami, respectively. Gaurav Shah, M.D., Chief Executive Officer, will take part in a fireside chat and manag...
-

SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery Technology

JONESBORO, Ark.--(BUSINESS WIRE)--SylamoreBio, a biotechnology company pioneering advanced therapeutic delivery to the central nervous system (CNS) and other recalcitrant tissues, today announced it has entered into a research collaboration with Daiichi Sankyo (TSE: 4568) through its Daiichi Sankyo Research Institute San Diego. The collaboration will leverage SylamoreBio’s proprietary SyLEC delivery technology in tandem with the world-class drug discovery and development expertise of Daiichi Sa...
-

ACCO Brands Corporation Announces Fourth Quarter and Full Year 2025 Earnings Webcast

LAKE ZURICH, Ill.--(BUSINESS WIRE)--ACCO Brands Corporation Announces Fourth Quarter and Full Year 2025 Earnings Webcast...
-

Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology

ST. LOUIS--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni™ mass spectrometer to enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants. New releases in Bruker ProteoScape™, OmniScape™, and GlycoScape™ software now support database-independent PTM discovery, confident proteoform characterizatio...
-

Core Scientific, Inc. Schedules Fourth Quarter Fiscal Year 2025 Earnings Release, Conference Call and Webcast

AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation, today announced it will release its fourth quarter and fiscal year 2025 financial results after the financial markets close on Monday, March 2, 2026. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the fourth quar...
-

PENN Entertainment Appoints Three New Independent Directors to Board

WYOMISSING, Pa.--(BUSINESS WIRE)--PENN Entertainment, Inc. (Nasdaq: PENN) (“PENN” or the “Company”) today announced the appointment of three new independent directors, Heather Ace, Jeffrey Fox and Fabio Schiavolin, to its Board of Directors (the “Board”), effective immediately. In connection with these appointments, the Company has entered into a cooperation agreement with HG Vora Capital Management, LLC and certain of its affiliates (collectively, “HG Vora”). David Handler, Chair of PENN’s Boa...